March 4th 2014 : Integragen will present at the "7th Annual European Life Sciences CEO Forum" on March 4th and 5th, 2014 in Zurich
14:30 : Bernard Courtieu - CEO, to speak about our company.
Results of a new study were published in Frontiers in Genetics which support the association of common genetic variants in the development of autism.
IntegraGen's mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests for autism and oncology based on these discoveries. The company also strives to be a leader in providing cutting edge genomic services to academic researchers and life sciences companies based on it's technological expertise and scientific know how.